An International Retrospective Observational Study of Liver Functional Deterioration After Repeat Liver Resection for Patients with Hepatocellular Carcinoma

Whether albumin and bilirubin levels, platelet counts, ALBI, and ALPlat scores could be useful for the assessment of permanent liver functional deterioration after repeat liver resection was examined, and the deterioration after laparoscopic procedure was evaluated. For 657 patients with liver resection of segment or less in whom results of plasma albumin and bilirubin levels and platelet counts before and 3 months after surgery could be retrieved, liver functional indicators were compared before and after surgery. There were 268 patients who underwent open repeat after previous open liver resection, and 224 patients who underwent laparoscopic repeat after laparoscopic liver resection. The background factors, liver functional indicators before and after surgery and their changes were compared between both groups. Plasma levels of albumin ( = 0.006) and total bilirubin ( = 0.01) were decreased, and ALBI score ( = 0.001) indicated worse liver function after surgery. Laparoscopic group had poorer preoperative performance status and liver function. Changes of liver functional values before and after surgery and overall survivals were similar between laparoscopic and open groups. Plasma levels of albumin and bilirubin and ALBI score could be the indicators for permanent liver functional deterioration after liver resection. Laparoscopic group with poorer conditions showed the similar deterioration of liver function and overall survivals to open group.

Citing Articles

Revisiting the Institut Mutualiste Montsouris Difficulty Classification of Laparoscopic Liver Resection with the Data from a Personal Series-Evaluations for the Difficulty of Left Medial Sectionectomy and Length of Hospital Stay.

Morise Z J Pers Med. 2024; 14(3).

PMID: 38540975 PMC: 10970809. DOI: 10.3390/jpm14030232.

Safety and Feasibility of Laparoscopic Parenchymal-Sparing Hepatectomy for Lesions with Proximity to Major Vessels in Posterosuperior Liver Segments 7 and 8.

Katagiri H, Nitta H, Kanno S, Umemura A, Takeda D, Ando T Cancers (Basel). 2023; 15(7).

PMID: 37046738 PMC: 10093396. DOI: 10.3390/cancers15072078.

Laparoscopic Repeat Liver Resection-Selecting the Best Approach for Repeat Liver Resection.

Morise Z, Katsuno H, Kikuchi K, Endo T, Matsuo K, Asano Y Cancers (Basel). 2023; 15(2).

PMID: 36672369 PMC: 9857037. DOI: 10.3390/cancers15020421.

Caudal Approach to Laparoscopic Liver Resection-Conceptual Benefits for Repeated Multimodal Treatment for Hepatocellular Carcinoma and Extended Right Posterior Sectionectomy in the Left Lateral Position.

Endo T, Morise Z, Katsuno H, Kikuchi K, Matsuo K, Asano Y Front Oncol. 2022; 12:950283.

PMID: 35898874 PMC: 9309811. DOI: 10.3389/fonc.2022.950283.

References

Llovet J, Fuster J, Bruix J . The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004; 10(2 Suppl 1):S115-20. DOI: 10.1002/lt.20034. View

Soubrane O, Schwarz L, Cauchy F, Perotto L, Brustia R, Bernard D . A Conceptual Technique for Laparoscopic Right Hepatectomy Based on Facts and Oncologic Principles: The Caudal Approach. Ann Surg. 2014; 261(6):1226-31. DOI: 10.1097/SLA.0000000000000737. View

Kanazawa A, Tsukamoto T, Shimizu S, Kodai S, Yamamoto S, Yamazoe S . Laparoscopic liver resection for treating recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2013; 20(5):512-7. DOI: 10.1007/s00534-012-0592-9. View

Morise Z, Ciria R, Cherqui D, Chen K, Belli G, Wakabayashi G . Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepatobiliary Pancreat Sci. 2015; 22(5):342-52. DOI: 10.1002/jhbp.215. View

Lau W, Leung T, Yu S, Ho S . Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003; 237(2):171-9. PMC: 1522146. DOI: 10.1097/01.SLA.0000048443.71734.BF. View

El-Serag H, Marrero J, Rudolph L, Reddy K . Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008; 134(6):1752-63. DOI: 10.1053/j.gastro.2008.02.090. View

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334(11):693-9. DOI: 10.1056/NEJM199603143341104. View

Hwang S, Lee S, Belghiti J . Liver transplantation for HCC: its role: Eastern and Western perspectives. J Hepatobiliary Pancreat Sci. 2009; 17(4):443-8. DOI: 10.1007/s00534-009-0241-0. View

Pinato D, Sharma R, Allara E, Yen C, Arizumi T, Kubota K . The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2016; 66(2):338-346. DOI: 10.1016/j.jhep.2016.09.008. View

10.

Tomishige H, Morise Z, Kawabe N, Nagata H, Ohshima H, Kawase J . Caudal approach to pure laparoscopic posterior sectionectomy under the laparoscopy-specific view. World J Gastrointest Surg. 2013; 5(6):173-7. PMC: 3750128. DOI: 10.4240/wjgs.v5.i6.173. View

11.

Capussotti L, Ferrero A, Vigano L, Polastri R, Tabone M . Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol. 2007; 35(1):11-5. DOI: 10.1016/j.ejso.2007.06.005. View

12.

Ryder S . Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003; 52 Suppl 3:iii1-8. PMC: 1867754. DOI: 10.1136/gut.52.suppl_3.iii1. View

13.

Miyama A, Morise Z, Aldrighetti L, Belli G, Ratti F, Cheung T . Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels. Cancers (Basel). 2021; 13(13). PMC: 8268302. DOI: 10.3390/cancers13133187. View

14.

Johnson P, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves H . Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2014; 33(6):550-8. PMC: 4322258. DOI: 10.1200/JCO.2014.57.9151. View

15.

Kudo M, Finn R, Qin S, Han K, Ikeda K, Piscaglia F . Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018; 391(10126):1163-1173. DOI: 10.1016/S0140-6736(18)30207-1. View

16.

Wakabayashi G, Cherqui D, Geller D, Han H, Kaneko H, Buell J . Laparoscopic hepatectomy is theoretically better than open hepatectomy: preparing for the 2nd International Consensus Conference on Laparoscopic Liver Resection. J Hepatobiliary Pancreat Sci. 2014; 21(10):723-31. DOI: 10.1002/jhbp.139. View

17.

Finn R, Qin S, Ikeda M, Galle P, Ducreux M, Kim T . Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020; 382(20):1894-1905. DOI: 10.1056/NEJMoa1915745. View

18.

Morise Z, Aldrighetti L, Belli G, Ratti F, Belli A, Cherqui D . Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. Br J Surg. 2020; 107(7):889-895. DOI: 10.1002/bjs.11436. View

19.

Yamamoto G, Taura K, Ikai I, Fujikawa T, Nishitai R, Kaihara S . ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure. Surgery. 2019; 167(2):410-416. DOI: 10.1016/j.surg.2019.09.021. View

20.

Rahbari N, Mehrabi A, Mollberg N, Muller S, Koch M, Buchler M . Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 2011; 253(3):453-69. DOI: 10.1097/SLA.0b013e31820d944f. View